Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
Class III · Ongoing
Failed dissolution specifications.
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot# 2145283, Exp Date: 31-Mar-2030.
- Recalling firm
- Supernus Pharmaceuticals, Inc., Rockville, MD
- Classification
- Class III (unlikely to cause harm)
- Status
- Ongoing
- Quantity
- 11304 bottles
- Distribution
- US Nationwide.
- Recall initiated
- August 31, 2026
- Classified
- September 3, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0833-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0833-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →